J Mocco, MD
Neurological Surgery · New York, NYNPI 1144425067
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.8%), ownership interests and other — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Imperative Care, Inc at 42.0% of the total. Reporting peaked in 2019 at $546,711 and has fallen 63.2% since, to $200,980 in 2025. Among neurological surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $5616.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Imperative Care, Inc$673K
- Corindus Inc.$528K
- Medtronic$230K
- NICO Corporation$75K
- Kaneka Medical America LLC$29K
- Irras USA, Inc.$28K
- plus $39K from 19 others
Across 7 payments — averaging $171,917 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$951K
- Stryker$236K
- Microvention, Inc.$13K
- Sequent Medical, Inc.$3K
Across 33 payments — averaging $409,689 each. An ownership or investment interest held by the physician or an immediate family member.
- Imperative Care, Inc$13M
- Tulavi Therapeutics, Inc.$255K
- Viseon, Inc.$113K
- Borvo Medical, Inc.$75K
- Kandu, Inc.$44K
- Viz.ai, Inc.$0
What the payments were for
- Royalty or licence$82,5345%
- Consulting fees$748,43547%
- Speaking & faculty fees$60,1584%
- Travel & lodging$14,8481%
- Food & beverage$15,8461%
- Ownership interest$535,88833%
- Other$143,0189%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Imperative Care, Inc | 131 | $672,812 |
| Corindus Inc. | 7 | $528,149 |
| Medtronic(2 entities) | 17 | $229,642 |
| NICO Corporation | 2 | $75,000 |
| Kaneka Medical America LLC | 1 | $28,890 |
| Irras USA, Inc. | 5 | $27,670 |
| Philips North America LLC | 4 | $12,942 |
| Boston Scientific | 2 | $8,388 |
| Microvention, Inc. | 20 | $3,105 |
| Viseon, Inc. | 1 | $3,000 |
| BTG International Inc. | 1 | $2,500 |
| Stryker | 25 | $1,864 |
| Integra Lifesciences Corporation | 5 | $1,497 |
| Medical Device Business Services, Inc. | 22 | $1,384 |
| Siemens Medical Solutions USA, Inc. | 10 | $897 |
| Balt USA, LLC | 7 | $654 |
| Johnson & Johnson | 8 | $618 |
| Inspiremd Ltd | 2 | $363 |
| Penumbra, Inc. | 7 | $320 |
| Asahi Intecc CO., LTD. | 1 | $316 |
| Scientia Vascular | 3 | $270 |
| Microtransponder, Inc. | 1 | $259 |
| Elekta, Inc. | 1 | $162 |
| Cook Medical LLC | 1 | $23 |
| Phenox Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOOM 88-T LARGE DISTAL PLATFORM$652,399
- RIST$114,699
- Rist-5F$110,852
- mild Device Kit$75,000
- Apheresis Machine$28,890
- IRRAflow$27,250
- Ultrasound Enabling Functions$12,299
- GENERAL - THERAPIES$8,388
- ZOOM RDL RADIAL ACCESS SYSTEM, 103CM$5,715
- Pipeline$3,932
- MaxView System - Lateral Set$3,000
- Imperative Care Zoom$2,436
- Imperative Care TracStar$2,436
- TracStarLargeDistalPlatform$1,604
- Zoom88LargeDistalPlatform$1,604
- Zoom88_TLargeDitalPlatform$1,604
- ZoomReperfusionCatheter$1,604
- PHIL$1,254
- HAKIM$1,250
- AURORA SURGISCOPE$1,250
How this compares
$1,600,727 in reported general payments places this provider in the 95th percentile of 446 neurological surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $161 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in New York
- Alejandro BerensteinNew York$1.1M
- Darryl LauNew York$915K
- Mark BilskyNew York$903K
- Jan-Karl BurkhardtNew York$441K
- Dean ChouNew York$383K
- Reade DeleacyNew York$329K
- Johanna FifiNew York$326K
- David LangerNew York$258K
- Ali BaajNew York$240K
- Viviane TabarNew York$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.